Nationwide Fund Advisors’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q4 | – | Sell |
-887
| Closed | -$37K | – | 1176 |
|
2017
Q3 | $37K | Hold |
887
| – | – | ﹤0.01% | 3066 |
|
2017
Q2 | $37K | Sell |
887
-778
| -47% | -$32.5K | ﹤0.01% | 3078 |
|
2017
Q1 | $93K | Buy |
1,665
+421
| +34% | +$23.5K | ﹤0.01% | 2864 |
|
2016
Q4 | $47K | Sell |
1,244
-8
| -0.6% | -$302 | ﹤0.01% | 3012 |
|
2016
Q3 | $50K | Sell |
1,252
-25
| -2% | -$998 | ﹤0.01% | 3045 |
|
2016
Q2 | $92K | Buy |
1,277
+157
| +14% | +$11.3K | ﹤0.01% | 2945 |
|
2016
Q1 | $90K | Hold |
1,120
| – | – | ﹤0.01% | 2865 |
|
2015
Q4 | $85K | Sell |
1,120
-1,328
| -54% | -$101K | ﹤0.01% | 2895 |
|
2015
Q3 | $938K | Hold |
2,448
| – | – | ﹤0.01% | 1761 |
|
2015
Q2 | $1.02M | Buy |
2,448
+1,288
| +111% | +$535K | ﹤0.01% | 1838 |
|
2015
Q1 | $551K | Sell |
1,160
-264
| -19% | -$125K | ﹤0.01% | 2187 |
|
2014
Q4 | $527K | Buy |
1,424
+658
| +86% | +$244K | ﹤0.01% | 2154 |
|
2014
Q3 | $181K | Buy |
+766
| New | +$181K | ﹤0.01% | 2744 |
|